Xilio Therapeutics, Inc.

Q3 2026 13F Holders

Symbol
XLO
CUSIP
98422T100
Type
Equity
Class
COM
Num filers
1
Total reported value, excl. options
$5.89M
Manager Report Date Value ($000) Shares Option Type